share_log

復星醫藥：翌日披露報表-股份購回

FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK

Hong Kong Stock Exchange ·  Jun 25 18:47
Summary by Futu AI
上海復星醫藥(集團)股份有限公司於2024年6月25日完成了股份購回活動，根據香港聯合交易所有限公司主板上市規則第13.25A條的規定進行披露。該公司在上海證券交易所購回了1,160,800股普通股，每股購回價格介於RMB 22.03至RMB 22.25之間，總支付價格為RMB 25,722,630。購回的股份將被持作庫存股份，並非註銷。購回後，公司的已發行股份總數由2,120,458,211股減少至2,119,297,411股，庫存股份數目增加至1,160,800股。此次購回股份佔公司於購回授權決議通過當日已發行股份的0.05%。購回授權的決議於2023年6月28日獲通過，公司可根據購回授權購回的股份總數為212,021,611股。購回活動後，公司將遵守相關規定，至2024年7月25日止不會進行任何新股發行或庫存股份再出售或轉讓。
上海復星醫藥(集團)股份有限公司於2024年6月25日完成了股份購回活動，根據香港聯合交易所有限公司主板上市規則第13.25A條的規定進行披露。該公司在上海證券交易所購回了1,160,800股普通股，每股購回價格介於RMB 22.03至RMB 22.25之間，總支付價格為RMB 25,722,630。購回的股份將被持作庫存股份，並非註銷。購回後，公司的已發行股份總數由2,120,458,211股減少至2,119,297,411股，庫存股份數目增加至1,160,800股。此次購回股份佔公司於購回授權決議通過當日已發行股份的0.05%。購回授權的決議於2023年6月28日獲通過，公司可根據購回授權購回的股份總數為212,021,611股。購回活動後，公司將遵守相關規定，至2024年7月25日止不會進行任何新股發行或庫存股份再出售或轉讓。
Fosun Pharma (Group) Co., Ltd. of Shanghai completed a share repurchase activity on June 25, 2024, and disclosed it in accordance with Rule 13.25A of the Listing Rules of the Main Board of The Stock Exchange of Hong Kong Limited. The company repurchased 1,160,800 ordinary shares on the Shanghai Stock Exchange, with a repurchase price per share ranging from RMB 22.03 to RMB 22.25, with a total payment of RMB 25,722,630. The repurchased shares will be held as treasury stock and will not be cancelled. After the repurchase, the total number of issued shares of the company decreased from 2,120,458,211 to 2,119,297,411, and the number of treasury shares increased to 1,160,800. The repurchased shares accounted for 0.05% of the total issued shares of the company on the day the repurchase authorization...Show More
Fosun Pharma (Group) Co., Ltd. of Shanghai completed a share repurchase activity on June 25, 2024, and disclosed it in accordance with Rule 13.25A of the Listing Rules of the Main Board of The Stock Exchange of Hong Kong Limited. The company repurchased 1,160,800 ordinary shares on the Shanghai Stock Exchange, with a repurchase price per share ranging from RMB 22.03 to RMB 22.25, with a total payment of RMB 25,722,630. The repurchased shares will be held as treasury stock and will not be cancelled. After the repurchase, the total number of issued shares of the company decreased from 2,120,458,211 to 2,119,297,411, and the number of treasury shares increased to 1,160,800. The repurchased shares accounted for 0.05% of the total issued shares of the company on the day the repurchase authorization resolution was passed. The resolution on repurchase authorization was passed on June 28, 2023, and the total number of shares that the company can repurchase according to the repurchase authorization is 212,021,611. After the repurchase activity, the company will comply with relevant regulations and will not conduct any new share issuance or resell or transfer treasury shares until July 25, 2024.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.